5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Jushi Holdings's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 11.56%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Jushi Holdings's 5-Year ROIIC % or its related term are showing as below:
JUSHF's 5-Year ROIIC % is ranked better than 66% of 900
companies
in the Drug Manufacturers industry
Industry Median: 2.405
vs JUSHF: 11.56
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Jushi Holdings 5-Year ROIIC % Related Terms
Jushi Holdings 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Jushi Holdings's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jushi Holdings 5-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Jushi Holdings's 5-Year ROIIC % falls into.
Jushi Holdings's 5-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( 2.176 (Dec. 2025) - -16.554 (Dec. 2020) )
/
( 386.363 (Dec. 2025) - 252.564 (Dec. 2020) )
=
18.73
/
133.799
=
14.00%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Jushi Holdings (JUSHF) has a 5-Year ROIIC % of 11.56 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Jushi Holdings and its competitors. According to the industry distribution chart, Jushi Holdings ranks #306 out of 900 companies in the Drug Manufacturers industry, placing it in the top 34%.
Is Jushi Holdings' 5-Year ROIIC % too high?
Jushi Holdings' current 5-Year ROIIC % is 11.56. The Drug Manufacturers industry median 5-Year ROIIC % is 2.41. Jushi Holdings' value of 11.56 is 380.7% above this industry median. Based on the distribution chart, Jushi Holdings ranks #306 out of 900 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jushi Holdings has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jushi Holdings' 5-Year ROIIC % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jushi Holdings ranks #306 out of 900 companies for 5-Year ROIIC %. This puts Jushi Holdings in the upper half of its industry. The industry median 5-Year ROIIC % is 2.41. Jushi Holdings' value of 11.56 is 380.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Drug Manufacturers company?
The median 5-Year ROIIC % among Drug Manufacturers companies is 2.41, based on 900 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jushi Holdings's current 5-Year ROIIC % of 11.56 is 380.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Jushi Holdings and its competitors. For the Drug Manufacturers industry, the median 5-Year ROIIC % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jushi Holdings's current 5-Year ROIIC % is 11.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jushi Holdings stock overvalued right now?
Based on GuruFocus' analysis, Jushi Holdings (JUSHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.51, compared to a current price of $0.45 — trading 12.3% below its estimated fair value. The current 5-Year ROIIC % is 11.56 and 380.7% above the Drug Manufacturers industry median of 2.41. Jushi Holdings' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Jushi Holdings (JUSHF), the current 5-Year ROIIC % is 11.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jushi Holdings (JUSHF) Overvalued in 2026?
Based on GuruFocus' analysis, Jushi Holdings stock appears to be undervalued.
The current stock price of $0.45 is trading 12.3% below its estimated GF Value™ of $0.51.
GuruFocus considers Jushi Holdings to be Modestly Undervalued.
Key valuation signals for JUSHF:
5-Year ROIIC %: 11.56
GF Value™: $0.51 vs. price of $0.45 (12.3% below fair value)
Industry Position: 380.7% above the Drug Manufacturers median (#306 of 900)
No single metric tells the full story. See the JUSHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Nature's Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.
51GF Score
Get the complete analysis for JUSHF
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JUSHF has been successfully added to your 
